Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) Consolidated Diluted EPS Stands At $-1.0101

0

For the period ended 2015-12-31, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) delivered annual basic consolidated EPS of $-1.0223. In terms of quarterly performance, the basic consolidated EPS was $-1.0223 for the quarter ended 2015-12-31.

What about EPS from continuing operations?

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) produced $-1.0223 in basic EPS from continuing operations for the annual period ended 2015-12-31. For the quarter, basic EPS from continuing operations was $-1.0223 for the three-month period ended 2015-12-31.

how much did parent contribute in EPS?

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) received basic EPS boost of $-1.0223 from its parent company for the annual period ended 2015-12-31. For quarterly metrics, basic EPS contribution from the parent company was $-1.0223 for the three-month period ended 2015-12-31.

Basic net EPS

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) posted basic net EPS of $-1.02 for the annual period ended 2015-12-31. On quarterly basis, the basic net EPS for the quarter ended 2015-12-31 was $-1.02.

Consolidated diluted EPS

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) produced annual consolidated diluted EPS of $-1.0101 for the period ended 2015-12-31. But consolidated diluted EPS stood at $-1.0101 for the quarter ended 2015-12-31.

Basic diluted EPS

Basic diluted EPS of $-1.0101 came from continuing operation for the annual period ended 2015-12-31. In terms of quarterly performance, diluted EPS from continuing operations was $-1.0101 for the quarter ended 2015-12-31.

Net diluted EPS

The company posted net diluted EPS of $-1.03 for the annual period ended 2015-12-31. Coming to the quarter, it posted net diluted EPS of $-1.03 for the three-month period ended 2015-12-31.

Diluted EPS from parent

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) received diluted EPS boost of $-1.0101 from the parent company for the annual period ended 2015-12-31. For the quarter, diluted EPS from the parent was $-1.0101 for the quarter ended 2015-12-31.

For the annual period ended 2015-12-31, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) produced net basic EPS of $-1.02. On quarterly basis, it posted basic net EPS of $-1.02, which was for the three-month period ended 2015-12-31.

The annual average of the company’s basic shares outstanding was 13.276 for the period ended 2015-12-31. The quarterly average of basic shares outstanding was 13.276 for the quarter ended 2015-12-31.

The company had diluted shares outstanding of 13.437 for the annual period ended 2015-12-31 and 13.437 for the quarterly period ended 2015-12-31.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)